Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia
Clinical Neuropsychopharmacology and Therapeutics · 2020
DOI: 10.5234/cnpt.11.43 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2020. Verfasst von Reiji Yoshimura und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yoshimura, R., Ikenouchi, A., & Konishi, Y. (2020). Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.11.43
Vancouver
Yoshimura R, Ikenouchi A, Konishi Y. Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia. Clinical Neuropsychopharmacology and Therapeutics. 2020. doi:10.5234/cnpt.11.43
BibTeX
@article{Yoshimura2020,
author = {Yoshimura, Reiji and Ikenouchi, Atsuko and Konishi, Yuki},
title = {Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia},
journal = {Clinical Neuropsychopharmacology and Therapeutics},
year = {2020},
doi = {10.5234/cnpt.11.43}
}
EUVIMED